Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Koninklijke Philips NVRYLPF 70 Free Cash Flow per Share is $1.95 as of Jun. 2026. GuruFocus rates RYLPF with a GF Score™ of 70/100 and a GF Value™ of $25.19 (Fairly Valued). The stock has 2 warning signs investors should review. Among 585 Medical Devices & Instruments companies, Koninklijke Philips NV ranks worse than 170940% on this metric.
Koninklijke Philips NV's Free Cash Flow per Share for the
three
months ended in Jun. 2026 was $0.26.
Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in Jun. 2026 was $1.95.
During the past 12 months, the average Free Cash Flow per Share Growth Rate of Koninklijke Philips NV was 179.80% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the FCF Growth Rate using Free Cash Flow per Share data.
The historical rank and industry rank for Koninklijke Philips NV's Free Cash Flow per Share or its related term are showing as below:
During the past 13 years, Koninklijke Philips NV's highest 3-Year average Free Cash Flow per Share Growth Rate was 162.50% per year. The lowest was -64.20% per year. And the median was 6.15% per year.
RYLPF's 3-Year FCF Growth Rate is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 18 * Ranked among companies with meaningful 3-Year FCF Growth Rate only.
Koninklijke Philips NV (OTCPK:RYLPF) Free Cash Flow per Share Explanation
Free Cash Flow is very close to Warren Buffett's definition of Owner's Earnings, except that in Warren Buffett's Owner's Earnings, the spending for Property, Plant, and Equipment is only for maintenance (replacement), while in the Free Cash Flow calculation, the cost of new Property, Plant, and Equipment due to business expansion is also deducted. There, Free Cash Flow is more conservative than Owner's Earnings.
In Don Yacktman's calculation of forward rate of return, he uses Free Cash Flow for the calculation. Yacktman explained the forward rate of return concept in detail in his interview with GuruFocus. Yacktman defines forward rate of return as the normalized free cash flow yield plus real growth plus inflation.
This is what Yacktman said in his March 2012 interview - when the S&P 500 was at 1400:
If the business is stable, this calculation is fairly straightforward. For instance, on the S&P 500 we would normalize earnings. We would then calculate what percentage of those earnings are not reinvested in the underlying businesses and are therefore free. Historically, for the S&P 500, this has been just under 50% of earnings. Currently, we expect the S&P to earn about 70 on a normalized basis, a number which is far below reported earnings due to our adjusting for record high profit margins. $70 X ½ / 1400 gives you a normalized free cash flow yield of approximately 2.5%.
The historical real growth rate of the S&P 500 (companies) is about 1.5%. Assuming an inflation rate of 2.5%, the forward rate of return on an investment in the S&P 500 is about 6.5% today (2.5% free cash flow yield plus 1.5% real growth plus 2.5% inflation).
For the growth part of the Forward Rate of Return calculation, GuruFocus uses the 5-year average growth rate of EBITDA per share as the growth rate, and the growth rate is always capped at 20%. For the Free Cash Flow we use per share data averaged over five years. The reason we use five years is because research shows that five years is the length of the typical business cycle.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Free Cash Flow within a report period can be affected by management's decisions of capital spending. Therefore, it is important to look at long term when it comes to Free Cash Flow.
Koninklijke Philips NV Free Cash Flow per Share Related Terms
Koninklijke Philips NV Free Cash Flow per Share Historical Data
* Premium members only.
The historical data trend for Koninklijke Philips NV's Free Cash Flow per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Koninklijke Philips NV Free Cash Flow per Share Chart
RYLPF vs ABT, SYK, MDT: Free Cash Flow per Share Comparison
For the Medical Devices subindustry, Koninklijke Philips NV's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Koninklijke Philips NV Price-to-Free-Cash-Flow vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Koninklijke Philips NV's Price-to-Free-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Koninklijke Philips NV's Price-to-Free-Cash-Flow falls into.
Koninklijke Philips NV Free Cash Flow per Share Calculation
Free Cashflow per Share is the amount of Free Cashflow per outstanding share of the company's stock.
Free Cash Flow is considered one of the most important parameters to measure a company's earnings power by value investors because it is not subject to estimates of Depreciation, Depletion and Amortization (DDA). However, when we look at the Free Cash Flow, we should look from a long term perspective, because any year's Free Cash Flow can be drastically affected by the spending on Property, Plant, & Equipment (PPE) of the business in that year. Over the long term, Free Cash Flow should give pretty good picture on the real earnings power of the company.
Note: GuruFocus does not calculate Free Cash Flow Per Share when Capital Expenditure is 0.
Koninklijke Philips NV's Free Cash Flow Per Share for the fiscal year that ended in Dec. 2025 is calculated as
Free Cash Flow per Share for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.95
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Free Cash Flow per Share of $1.95 mean?
Koninklijke Philips NV (RYLPF) has a Free Cash Flow per Share of $1.95 as of Jun. 2026. Free cash flow per share represents the pre-share value of cash following operating and capital expenditures. View historical data on Koninklijke Philips NV and its competitors. According to the industry distribution chart, Koninklijke Philips NV ranks #999999 out of 585 companies in the Medical Devices & Instruments industry.
Is Koninklijke Philips NV's Free Cash Flow per Share too high?
Koninklijke Philips NV's current Free Cash Flow per Share is $1.95. The Medical Devices & Instruments industry median Free Cash Flow per Share is 18.00. Koninklijke Philips NV's value of $1.95 is 89.2% below this industry median. Based on the distribution chart, Koninklijke Philips NV ranks #999999 out of 585 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Koninklijke Philips NV has a GF Score™ of 70/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Koninklijke Philips NV's Free Cash Flow per Share compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Koninklijke Philips NV ranks #999999 out of 585 companies for Free Cash Flow per Share. This places Koninklijke Philips NV in the lower half of its industry. The industry median Free Cash Flow per Share is 18.00. Koninklijke Philips NV's value of $1.95 is 89.2% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Free Cash Flow per Share for a Medical Devices & Instruments company?
The median Free Cash Flow per Share among Medical Devices & Instruments companies is 18.00, based on 585 companies in the industry. Companies in the top quartile (top 25%) have a Free Cash Flow per Share significantly above this median, while those in the bottom quartile fall well below. However, Free Cash Flow per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Koninklijke Philips NV's current Free Cash Flow per Share of $1.95 is 89.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Free Cash Flow per Share mean?
A high Free Cash Flow per Share can signal that a stock is expensive relative to its fundamentals. Free cash flow per share represents the pre-share value of cash following operating and capital expenditures. View historical data on Koninklijke Philips NV and its competitors. For the Medical Devices & Instruments industry, the median Free Cash Flow per Share is 18.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Koninklijke Philips NV's current Free Cash Flow per Share is $1.95. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Koninklijke Philips NV stock overvalued right now?
Based on GuruFocus' analysis, Koninklijke Philips NV (RYLPF) is currently considered Fairly Valued. The stock's GF Value™ is $25.19, compared to a current price of $27.58 — trading 9.5% above its estimated fair value. The current Free Cash Flow per Share is $1.95 and 89.2% below the Medical Devices & Instruments industry median of 18.00. Koninklijke Philips NV's overall GF Score™ is 70/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Free Cash Flow per Share calculated?
Free Cash Flow per Share is calculated from a company's financial statements. For Koninklijke Philips NV (RYLPF), the current Free Cash Flow per Share is $1.95 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Koninklijke Philips NV (RYLPF) Overvalued in 2026?
Based on GuruFocus' analysis, Koninklijke Philips NV stock appears to be overvalued.
The current stock price of $27.58 is trading 9.5% above its estimated GF Value™ of $25.19.
GuruFocus considers Koninklijke Philips NV to be Fairly Valued.
Key valuation signals for RYLPF:
Free Cash Flow per Share: $1.95
GF Value™: $25.19 vs. price of $27.58 (9.5% above fair value)
Industry Position: 89.2% below the Medical Devices & Instruments median (#999999 of 585)
No single metric tells the full story. See the RYLPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Koninklijke Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. Nearly 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound and X-ray equipment, and image-guided therapy solutions. The connected care segment (under 30% of revenue) encompasses monitoring and analytics systems for hospitals, informatics business, and also houses the sleep and respiratory care segment. Personal health business (remainder of revenue) is mainly oral health and personal care product lines, which include electric toothbrushes and men's grooming and personal-care products.
70GF Score
Get the complete analysis for RYLPF
Free Cash Flow per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
RYLPF has been successfully added to your 
